We're trying to set the stage for integrating these ideas" Anthony Vella, professor and Boehringer Ingelheim Chair in ...

With an estimated four million Nigerians living with sickle cell disease (SCD), health experts are advocating the adoption of gene therapy as a curative treatment option for patients in the country.

With an estimated four million Nigerians affected by sickle cell disease, experts have called on the federal government to invest in the local production of gene therapy treatments. The appeal was ...

17–22 did not directly predict outcomes to checkpoint therapy. This is possibly related to the lack of single-cell granularity and spatial context in these studies and overlapping expression ...

grant Regenerative Medicine Advanced Therapy (RMAT) Designation for its drug OST-HER2. According to InvestingPro data, the company’s stock has declined 62% year-to-date, though analysts maintain ...

As favor in the general market swings away from cell therapy, Immatics’ CEO is choosing to focus on what he can control: raising the bar for his biotech’s investigational treatment.

What it is: Chelation involves the use of certain chemicals to remove toxic heavy metals, such as mercury and lead, from the body; all FDA-approved chelation therapy products require a ...

OS Therapies Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced it has submitted a request ...

Orca Bio is preparing to make a splash in the cell therapy market. The biotech has hired Steve Gavel as chief commercial officer, securing itself a leader with cell therapy expertise accrued at ...